ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
Abivax S.A.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026
$87.49−0.64 (-0.73%)
Close on Oct 19, 2026
Community
Notes and questions about Abivax from other investors
No posts about ABVX yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.